Phase 2 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form agreeing to take part in the trial.
- You are 18 years of age or older at the time of signing the consent form.
- You have been diagnosed with a specific type of bladder cancer (called transitional cell carcinoma) that is high-risk and has not grown into the muscle of the bladder wall — confirmed by a laboratory test on a tissue sample.
- If you had raised/lumpy tumors (called papillary tumors), a procedure to remove all visible tumors from your bladder (called TURBT) has already been completed.
- You have already received a full course of BCG treatment (a common bladder cancer therapy given directly into the bladder) but your bladder cancer has either not responded to it, come back, or persisted within certain time periods as defined by the trial (confirm with trial site for exact details).
Who may not be able to join:
- Your bladder cancer has grown into or through the bladder muscle, or has spread to other parts of the body.
- You have the same type of cancer present in other parts of your urinary tract (such as the urethra, ureters, or kidneys) at the same time.
- You are currently taking part in another clinical trial or have received an experimental treatment within the last 4 weeks.
- You have received any treatment given directly into the bladder (chemotherapy or immunotherapy) between your most recent bladder procedure and the start of this trial (a single dose given during that procedure may be acceptable — confirm with trial site).
- You have had chemotherapy, targeted drug therapy, or radiation therapy within the 2 weeks before starting this trial, or you are still experiencing side effects from a previous treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +541156164207
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
eficacy; Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.